SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-11-333946
Filing Date
2011-12-08
Accepted
2011-12-07 19:49:42
Documents
5
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A d263611d10qa.htm 10-Q/A 1283293
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER d263611dex311.htm EX-31.1 9539
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER d263611dex312.htm EX-31.2 9511
4 CERTIFICATION PURSUANT TO 18 U.S.C SECTION 1350 d263611dex321.htm EX-32.1 5078
5 CERTIFICATION PURSUANT TO 18 U.S.C SECTION 1350 d263611dex322.htm EX-32.2 5023
  Complete submission text file 0001193125-11-333946.txt   1313435
Mailing Address ONE CORPORATE WOODS DRIVE BRIDGETON MO 63044
Business Address ONE CORPORATE WOODS DRIVE BRIDGETON MO 63044 3146456600
KV PHARMACEUTICAL CO /DE/ (Filer) CIK: 0000057055 (see all company filings)

IRS No.: 430618919 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q/A | Act: 34 | File No.: 001-09601 | Film No.: 111249684
SIC: 2834 Pharmaceutical Preparations